A detailed history of Cambridge Advisors Inc. transactions in Danaher Corp stock. As of the latest transaction made, Cambridge Advisors Inc. holds 10,526 shares of DHR stock, worth $2.43 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
10,526
Previous 10,526 -0.0%
Holding current value
$2.43 Million
Previous $2.63 Million 11.3%
% of portfolio
0.66%
Previous 0.63%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$235.51 - $267.98 $17,663 - $20,098
-75 Reduced 0.71%
10,526 $2.63 Million
Q1 2024

Apr 16, 2024

SELL
$224.58 - $256.19 $141,485 - $161,399
-630 Reduced 5.61%
10,601 $2.65 Million
Q4 2023

Jan 16, 2024

SELL
$185.1 - $233.13 $95,881 - $120,761
-518 Reduced 4.41%
11,231 $2.6 Million
Q2 2023

Jul 13, 2023

SELL
$224.99 - $256.14 $131,394 - $149,585
-584 Reduced 4.74%
11,749 $2.82 Million
Q1 2023

Apr 13, 2023

SELL
$239.75 - $277.0 $11,987 - $13,850
-50 Reduced 0.4%
12,333 $3.11 Million
Q4 2022

Jan 23, 2023

SELL
$241.42 - $282.29 $22,693 - $26,535
-94 Reduced 0.75%
12,383 $0
Q3 2022

Oct 17, 2022

SELL
$247.06 - $1507.4 $52,623 - $321,076
-213 Reduced 1.68%
12,477 $3.22 Million
Q2 2022

Jul 18, 2022

SELL
$237.11 - $299.66 $80,617 - $101,884
-340 Reduced 2.61%
12,690 $3.22 Million
Q1 2022

May 05, 2022

SELL
$257.27 - $315.76 $141,241 - $173,352
-549 Reduced 4.04%
13,030 $3.82 Million
Q4 2021

Jan 14, 2022

SELL
$292.08 - $329.01 $31,836 - $35,862
-109 Reduced 0.8%
13,579 $4.47 Million
Q3 2021

Oct 19, 2021

SELL
$272.21 - $332.43 $409,948 - $500,639
-1,506 Reduced 9.91%
13,688 $4.17 Million
Q2 2021

Jul 21, 2021

SELL
$225.08 - $271.69 $109,163 - $131,769
-485 Reduced 3.09%
15,194 $4.08 Million
Q1 2021

Apr 22, 2021

BUY
$212.38 - $245.9 $5,521 - $6,393
26 Added 0.17%
15,679 $3.53 Million
Q4 2020

Jan 25, 2021

SELL
$212.5 - $245.46 $31,875 - $36,819
-150 Reduced 0.95%
15,653 $3.48 Million
Q3 2020

Oct 15, 2020

SELL
$177.16 - $215.33 $2,657 - $3,229
-15 Reduced 0.09%
15,803 $3.4 Million
Q2 2020

Jul 17, 2020

SELL
$128.7 - $176.83 $28,313 - $38,902
-220 Reduced 1.37%
15,818 $2.8 Million
Q1 2020

Apr 21, 2020

SELL
$121.39 - $169.05 $172,980 - $240,896
-1,425 Reduced 8.16%
16,038 $2.22 Million
Q4 2019

Jan 28, 2020

SELL
$133.47 - $153.48 $68,603 - $78,888
-514 Reduced 2.86%
17,463 $2.68 Million
Q3 2019

Oct 25, 2019

SELL
$135.4 - $146.47 $40,620 - $43,941
-300 Reduced 1.64%
17,977 $2.6 Million
Q2 2019

Jul 26, 2019

SELL
$124.88 - $143.73 $65,437 - $75,314
-524 Reduced 2.79%
18,277 $2.61 Million
Q1 2019

Apr 16, 2019

SELL
$97.62 - $132.29 $57,595 - $78,051
-590 Reduced 3.04%
18,801 $2.48 Million
Q4 2018

Jan 29, 2019

BUY
$94.85 - $109.54 $33,766 - $38,996
356 Added 1.87%
19,391 $2 Million
Q3 2018

Oct 24, 2018

SELL
$98.13 - $108.9 $69,672 - $77,319
-710 Reduced 3.6%
19,035 $2.07 Million
Q2 2018

Jul 30, 2018

BUY
$96.1 - $103.24 $96 - $103
1 Added 0.01%
19,745 $1.95 Million
Q1 2018

Apr 18, 2018

BUY
$92.16 - $103.8 $139,253 - $156,841
1,511 Added 8.29%
19,744 $1.93 Million
Q4 2017

Jan 26, 2018

SELL
$85.26 - $94.62 $144,856 - $160,759
-1,699 Reduced 8.52%
18,233 $1.69 Million
Q3 2017

Oct 27, 2017

BUY
$79.29 - $88.45 $1.58 Million - $1.76 Million
19,932
19,932 $1.71 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Cambridge Advisors Inc. Portfolio

Follow Cambridge Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Advisors Inc. with notifications on news.